Posted on

22 Aug

2018

A Q&A guide to pharmaceutical IP and competition law in Finland.

The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports. The Q&A is part of the Thomson Reuters’ Global Guide to Life Sciences law.

Read our Finland overview.

Service areas

Written by

Johan Åkermarck

Partner [email protected] +358 400 502 546

Latest Insights

Examining Off-label Medicine Use in Paediatric Healthcare

15 Dec 2023 Our life science experts Dr Juli Mansnérus, Charlotta Bonsdorff and Petro Vornanen seized the opportunity to contribute to th...

The Data Act Approved by the European Parliament

9 Nov 2023 Today, the European Parliament voted yes to formally approve the new Data Act. Following today's vote, the Data Act is expect...